Novavax is absent from Australia's 2021 vaccination schedule. But it could be a useful booster later on
- Written by: Cassandra Berry, Professor of Viral Immunology, Murdoch University
Novavax recently released excellent results from phase 3 clinical trials, finding its COVID-19 vaccine demonstrated 90.4% efficacy overall after two doses given three weeks apart.
The results, from close to 30,000 people in the United States and Mexico, found the vaccine demonstrated 100% protection against moderate and severe COVID-19, and was...
